Analysis of whether Zongertinib (Zongatinib) can be purchased in China, formal drug purchase channels and purchase precautions
Zongertinib (trade name: Zongertinib) is a new type of targeted drug mainly used to treat patients with non-small cell lung cancer with specific gene mutations. The drug has been approved for marketing in China, but due to its short time on the market, domestic hospitals and pharmacies currently have limited supply, so it may be temporarily difficult for some patients to purchase the drug directly. Nonetheless, as the drug supply chain gradually improves, access will be more convenient in the future.
In overseas markets, the versions of zongotinib that have been launched are mainly American original drugs, and the price per box is about 20 more than 10,000 yuan. There are currently no relevant generic drugs, which means that if patients choose to purchase them overseas, they need to bear higher costs and pay attention to transportation and storage conditions. Obtaining overseas drugs usually requires a doctor's prescription, medical records, and import procedures that comply with local laws and regulations to ensure that the source of the drugs is legal and safe.

Formal drug purchasing channels mainly include domestic listed pharmacies, certified hospital pharmacies, as well as participating in clinical trials or obtaining overseas drugs through international drug import companies. Patients should avoid obtaining drugs through informal or private channels to prevent health risks caused by counterfeit drugs or substandard quality. During use, you should be guided by a professional doctor to ensure that the dosage and medication regimen are scientific and reasonable.
When purchasing and using zongatinib, you also need to pay attention to the storage, medication cycle and potential adverse reactions of the drug. Because it is a targeted therapy drug that has specific requirements for the patient's genetic mutation type and physical condition, necessary genetic testing and medical evaluation must be completed before purchasing the drug. At the same time, close communication should be maintained with doctors, and treatment effects and adverse reactions should be regularly monitored to ensure safe and effective use of drugs.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)